Prostaglandin E2 (PGE2), an immunosuppressive monokine that increases intracellular cyclic AMP (cAMP) levels, stimulated Candida albicans germ tube formation. Dibutyryl cAMP (dB-cAMP) and isoproterenol, other compounds that increase cAMP levels, also stimulated germination. Gamma interferon (IFN--y), a product of cellular immune system activation, inhibited Candida germ tube formation, even in the presence of PGE2, dB-cAMP, and isoproterenol. Thus, PGE2 and IFN-y as well as having opposing roles in the suppression or activation of cell-mediated immunity, are also antagonists for the yeast-to-hyphal transition of C. albicans. were added to GBE medium in concentrations between 4 and 100 U. Dibutryl cyclic AMP (dB-cAMP) and isoproterenol (Sigma Chemical Co., St. Louis, Mo.) were examined at concentrations between 10-5 and 10' M. Higher concentrations of isoproterenol were toxic to the yeast cells. Isoproterenol was dissolved in 95% ethanol and diluted in medium to yield final ethanol concentrations of <0.1%. dB-cAMP was dissolved in phosphate-buffered saline and diluted in GBE medium. Controls of GBE broth containing between 0.1 and 0.001% ethanol were always incubated in parallel to the test samples. At these concentrations, ethanol had no effect on germ tube formation.
Candida albicans is an opportunistic dimorphic fungus which induces clinical symptoms of vaginitis in susceptible women. Hormonal alterations accompanying pregnancy or endocrinopathies, treatment with immunosuppressive medications, or changes in the vaginal microflora after antibiotic usage enhance vaginal infections by this organism (18) . Some women with candidal vaginitis also exhibit a deficiency in their cell-mediated immune response to C. albicans (22) . This appears to be related to a localized vaginal allergic response to C. albicans, components of semen, or other allergens (23) . Vaginal secretions from these women contain prostaglandin E2 (PGE2) (23) , a potent immunosuppressor (11) .
In this communication, we show that products of suppressed or activated lymphoid cells also affect the yeastto-hyphal transition of this organism. This will influence pathogenicity, since the hyphal form of C. albicans is associated with increased virulence (20, 21 were added to GBE medium in concentrations between 4 and 100 U. Dibutryl cyclic AMP (dB-cAMP) and isoproterenol (Sigma Chemical Co., St. Louis, Mo.) were examined at concentrations between 10-5 and 10' M. Higher concentrations of isoproterenol were toxic to the yeast cells. Isoproterenol was dissolved in 95% ethanol and diluted in medium to yield final ethanol concentrations of <0.1%. dB-cAMP was dissolved in phosphate-buffered saline and diluted in GBE medium. Controls of GBE broth containing between 0.1 and 0.001% ethanol were always incubated in parallel to the test samples. At these concentrations, ethanol had no effect on germ tube formation.
To further assess the effect of IFN--y on germination, IFN--y (40 U) in GBE medium was incubated with or without a 1:100 dilution of immunoglobulin G mouse monoclonal antibody to either human IFN-y (Interferon Science) or herpesvirus (control) (Serotec, Blackthorn, England). After 60 min at 37°C, an equal volume of C. albicans in GBE medium was added and germination was determined as described above.
The significance of altered germination rates in the presence of added compounds was evaluated by chi-square analysis, using the Yates correction factor.
Germination was enhanced by PGE2 at concentrations above 100 pg; greater than 75% stimulation was observed at concentrations of 500 pg and higher. In contrast, PGF2a was without effect on germination over the 20-pg to 10-ng range tested ( Fig. 1) .
In contrast to the stimulatory effect of PGE2, IFN--y inhibited germination. Maximal inhibition (35 to 50%) was obtained in the presence of 40 U of IFN-y. A second interferon, IFN-oa, was not inhibitory to C. albicans germ tube formation at comparable concentrations ( Fig. 2A) . The capacity of IFN--y to inhibit germination was obviated in the presence of monoclonal antibody to IFN--y (data not shown). To transition of this organism. This suggests that alterations in cAMP may not simply be a correlate of this transition but, instead, may be a trigger for morphogenesis. PGE2, at levels now shown to promote Candida germination, has previously been identified in the vaginal fluids of women with recurrent candidal vaginitis (23) . It was postulated that PGE2-mediated inhibition of cell-mediated immune responses, which leads to a reduction in IFN--y production (4, 7, 11, 14) , decreased the ability of phagocytes and cytotoxic lymphocytes to limit Candida proliferation. It can now be proposed that PGE2 also increases Candida infectivity by inducing the yeast-to-hyphal transition. The hyphal form of this organism is better able to adhere to mucosal cells than is the yeast form (20) and, thus, is more likely to invade host tissues and initiate clinical disease.
In women with intact cellular immunity, Candida-induced IFN--y production leads to immune system activation and elimination of the organism. The demonstration that IFN-y also directly inhibits Candida germination provides an additional mechanism whereby the immune response limits pathogenicity. The observation that products of activated lymphocytes inhibit Candida germ tube formation has been made previously (J. D. Sobel and M. Opitz, Abstr. Annu. Meet. Intersci. Conf. Antimicrob. Agents Chemother. Abstr. 581, p. 198, 1987) .
The mechanism of IFN-y inhibition of Candida germination remains to be elucidated. One intriguing possibility, currently under investigation, is that C. albicans possesses specific receptors for human IFN--y and that this interaction inhibits cAMP production in this organism. C. albicans does possess specific receptors reactive with human progesterone and corticosterone (15) and complement components C3d and iC3b (12) . In addition, fibrinogen, albumin, and transferrin also bind to this organism, by undetermined mechanisms (19) .
Candida vaginitis most often occurs during the luteal phase of the menstrual cycle (13), when cell-mediated immune responses to C. albicans are at their lowest level (A. Kalo-Klein and S. S. Witkin, Am. J. Obstet. Gynecol., in press). Under these conditions, IFN--y production is decreased. Conversely, PGE2 levels increase during the luteal phase due to progesterone stimulation of uterine prostaglandin production (1, 8, 16) . Similarly, immunosuppressed individuals may exhibit increased levels of PGE2 or decreased levels of IFN--y in their circulation. These alterations increase the ability of C. albicans to form germ tubes and initiate a clinical infection. Immunosuppressive drugs, by elevating cAMP production (3), can also increase susceptibility to candidiasis by a similar mechanism.
